US2022313775A1PendingUtilityA1

Targeting g3bp proteins to accelerate nerve regeneration

Assignee: UNIV SOUTH CAROLINAPriority: Feb 15, 2017Filed: Jun 14, 2022Published: Oct 6, 2022
Est. expiryFeb 15, 2037(~10.5 yrs left)· nominal 20-yr term from priority
A61K 38/10
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for using a peptide to effectively increase axon growth in both naive and injury-conditioned neurons.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A prophylactic method for accelerating nerve recovery treating nerve injury in a mammal comprising:
 introducing a polypeptide, wherein the polypeptide is amino acid sequence SEQ ID NO: 2, comprising between 15 and 20 amino acids to increase axon growth in neurons or accelerating nerve regeneration at a nerve injury site in the mammal; and   wherein the polypeptide interferes with function of stress granules and increases intra-axonal rates of translation of proteins needed for nerve regeneration.   
     
     
         2 . The method of  claim 1 , wherein the polypeptide specifically targets mRNA storage sites in neurons and increases rates of neuron regeneration. 
     
     
         3 . The method of  claim 1 , wherein the polypeptide disrupts G3BP functions. 
     
     
         4 . The method of  claim 3 , wherein disruption of G3BP functions:
 activates intra-axonal mRNA translation;   increases axon growth in neurons; and   accelerates nerve regeneration in vivo.   
     
     
         5 . The method of  claim 3 , wherein disruption of G3BP functions is accomplished via transfection of siRNA to promote siRNA-mediated knockdown of G3BP1. 
     
     
         6 . The method of  claim 5 , wherein disrupting G3BP1's function in an assembly of axonal stress granule structures increases intra-axonal protein synthesis and accelerates peripheral nervous system axon regeneration. 
     
     
         7 . The method of  claim 6 , wherein accelerated axon growth regeneration is facilitated by sequestering Imp61 mRNA from translation. 
     
     
         8 . A method of increasing axon growth in neurons or accelerating nerve regeneration disrupting G3BP functions comprising:
 overexpressing a dominant-negative protein, wherein the protein is introduced by a transporter molecule;   wherein the dominant-negative protein:
 disassembles axonal stress granule-like structures 
 activates intra-axonal mRNA translation; 
 increases axon growth in neurons; and 
 accelerates nerve regeneration in vivo; and 
 wherein the protein is amino acid sequence SEQ ID NO: 2. 
   
     
     
         9 . The method of  claim 8 , wherein the protein is cell permeable and targets mRNA storage sites in neurons. 
     
     
         10 . The method of  claim 8 , wherein preventing stress granule-like aggregation of axonal proteins during regeneration increases the rate of axon regrowth.

Join the waitlist — get patent alerts

Track US2022313775A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.